| 1 | [SID51085113] | Active | EC50 | 3.091 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus [AID1900, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | EC50 | 3.091 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus | | AID | 1900 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID51085113] | Active | EC50 | 3.892 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity [AID1902, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | EC50 | 3.892 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity | | AID | 1902 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 3 | [SID51085113] | Active | Potency | 3.9811 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID51085113] | Active | AC50 | 4.364 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells [AID449748, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | AC50 | 4.364 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells | | AID | 449748 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID51085113] | Active | AC50 | 5.291 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | AC50 | 5.291 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID51085113] | Active | Potency | 9.285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 9.285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID51085113] | Active | EC50 | 9.899 | Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression [AID1914, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | EC50 | 9.899 [uM] | | BioAssay | Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression | | AID | 1914 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 8 | [SID51085113] | Active | EC50 | 10.143 | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus [AID1915, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | EC50 | 10.143 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus | | AID | 1915 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID51085113] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID51085113] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID51085113] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID51085113] | Active | Potency | 18.3564 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 13 | [SID51085113] | Active | Potency | 18.3564 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 14 | [SID51085113] | Active | Potency | 18.3564 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 15 | [SID51085113] | Active | Potency | 19.9526 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 16 | [SID51085113] | Active | Potency | 19.9526 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 17 | [SID51085113] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 18 | [SID51085113] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 19 | [SID51085113] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID51085113] | Active | Potency | 31.6228 | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia [AID485349, Type: confirmatory] | serine-protein kinase ATM [Homo sapiens] [gi:71902540] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia | | AID | 485349 | | BioAssay type | confirmatory | | Target | serine-protein kinase ATM [Homo sapiens] [gi:71902540] | | PubMed | | | Data Table |  |
|
| 21 | [SID51085113] | Active | Potency | 31.6228 | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia [AID485349, Type: confirmatory] | serine-protein kinase ATM [Homo sapiens] [gi:71902540] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia | | AID | 485349 | | BioAssay type | confirmatory | | Target | serine-protein kinase ATM [Homo sapiens] [gi:71902540] | | PubMed | | | Data Table |  |
|
| 22 | [SID51085113] | Active | Potency | 56.2341 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 23 | [SID51085113] | Active | | | Counterscreen for antagonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective antagonists [AID651780, Type: screening] | GNA15 gene product [Homo sapiens] [gi:156104883] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | Counterscreen for antagonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective antagonists | | AID | 651780 | | BioAssay type | screening | | Target | GNA15 gene product [Homo sapiens] [gi:156104883] | | PubMed | | | Data Table |  |
|
| 24 | [SID51085113] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 25 | [SID51085113] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 26 | [SID51085113] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID51085113] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 28 | [SID51085113] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 29 | [SID51085113] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 30 | [SID51085113] | Active | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 31 | [SID51085113] | Active | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 32 | [SID51085113] | Active | | | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 [AID540275, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 | | AID | 540275 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 33 | [SID51085113] | Active | | | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 [AID540275, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 | | AID | 540275 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 34 | [SID51085113] | Active | | | MLPCN Streptokinase Expression Inhibition [AID1662, Type: screening] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | MLPCN Streptokinase Expression Inhibition | | AID | 1662 | | BioAssay type | screening | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 35 | [SID51085113] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID651785, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 651785 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 36 | [SID51085113] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID651785, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 651785 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 37 | [SID51085113] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 38 | [SID51085113] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 39 | [SID51085113] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 40 | [SID51085113] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 41 | [SID51085113] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 42 | [SID51085113] | Inactive | Potency | 0.4091 | qHTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1: Hit Validation [AID623958, Type: confirmatory] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Inactive | | Potency | 0.4091 [uM] | | BioAssay | qHTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1: Hit Validation | | AID | 623958 | | BioAssay type | confirmatory | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 43 | [SID51085113] | Inactive | Potency | 0.4091 | qHTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1: Hit Validation [AID623958, Type: confirmatory] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Inactive | | Potency | 0.4091 [uM] | | BioAssay | qHTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1: Hit Validation | | AID | 623958 | | BioAssay type | confirmatory | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 44 | [SID51085113] | Inactive | Potency | 0.4091 | qHTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1: Hit Validation [AID623959, Type: confirmatory] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Inactive | | Potency | 0.4091 [uM] | | BioAssay | qHTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1: Hit Validation | | AID | 623959 | | BioAssay type | confirmatory | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 45 | [SID51085113] | Inactive | Potency | 0.4091 | qHTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1: Hit Validation [AID623959, Type: confirmatory] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Inactive | | Potency | 0.4091 [uM] | | BioAssay | qHTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1: Hit Validation | | AID | 623959 | | BioAssay type | confirmatory | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 46 | [SID51085113] | Inactive | Potency | 31.6228 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 47 | [SID51085113] | Inactive | Potency | 31.6228 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 48 | [SID51085113] | Inactive | Potency | 35.4813 | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 49 | [SID51085113] | Inactive | Potency | 35.4813 | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 50 | [SID51085113] | Inactive | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 51085113 | | CID | 24891774 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|